Leah Sabin

Leah Sabin

Company: Regeneron

Job title: Director - Viral Vector Technologies


Leveraging Antibody Technology to Improve Targeting to Skeletal Muscles 4:30 pm

Overcoming the challenge of driving the capsid towards the skeletal muscle Understanding the obstacles to re-direct the capsid from other tissues Discussing future applications of antibody technology to support gene therapy for muscular disordersRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.